First Clinical Experience With [68Ga]Ga-FAPI-46-PET/CT Versus [18F]F-FDG PET/CT for Nodal Staging in Cervical Cancer

被引:17
作者
Wegen, Simone [1 ]
Roth, Katrin Sabine [2 ,3 ]
Weindler, Jasmin [2 ,3 ]
Claus, Karina [1 ]
Linde, Philipp [1 ]
Trommer, Maike [1 ]
Akuamoa-Boateng, Dennis [1 ]
van Heek, Lutz [2 ,3 ]
Baues, Christian [1 ]
Schoemig-Markiefka, Birgid [4 ]
Schomaecker, Klaus [2 ,3 ]
Fischer, Thomas [2 ,3 ]
Drzezga, Alexander [2 ,3 ,5 ,6 ]
Kobe, Carsten [2 ,3 ]
Koehler, Christhardt [7 ]
Marnitz, Simone [1 ]
机构
[1] Univ Hosp Cologne, Dept Radiat Oncol Cyberknife & Radiotherapy, Kerpener Str 62, D-50937 Cologne, Germany
[2] Univ Cologne, Fac Med, Dept Nucl Med, Cologne, Germany
[3] Univ Cologne, Univ Hosp Cologne, Cologne, Germany
[4] Univ Hosp Cologne, Inst Pathol, Cologne, Germany
[5] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany
[6] Forschungszentrum Julich, Inst Neurosci & Med INM 2, Mol Org Brain, Julich, Germany
[7] Asklepios Hosp Grp, Dept Special Operat & Oncol Gynecol, Asklepios Clin Hamburg Altona, Hamburg, Germany
关键词
FAPI PET; cervical cancer; FDG PET; surgical lymph node staging; CHEMORADIATION; METASTASES;
D O I
10.1097/RLU.0000000000004505
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
IntroductionIn several solid tumors, fibroblast activation protein (FAP) is overexpressed by cancer-associated fibroblasts in the tumor microenvironment. Preliminary evidence suggests that detection and staging are feasible with PET/CT imaging using [Ga-68]-radiolabeled inhibitors of FAP also in cervical cancer (CC). Our study aims to explore the accuracy of [Ga-68]Ga-fibroblast activation protein inhibitor (FAPI)-46 PET/CT and [F-18]F-FDG PET/CT compared with histopathological results of surgical lymph node (LN) staging before primary chemoradiation.MethodsSeven consecutive women with treatment-naive and biopsy-proven locally advanced CC underwent both whole-body [Ga-68]Ga-FAPI-46- and [F-18]F-FDG PET/CT, for imaging nodal staging before systematic laparoscopic lymphadenectomy of the pelvic and para-aortic region. Location and number of suspicious LNs in PET imaging were recorded and compared with the results of histopathological analysis, including immunohistochemical staining for FAP.ResultsAll 7 patients had focal uptake above background in their tumor lesions in [Ga-68]Ga-FAPI-46 PET/CT. [Ga-68]Ga-FAPI-46 PET/CT showed a higher tumor-to-background ratio (TBR) in primary tumor as well as in LN metastasis. Median TBRmax values using liver were 32.02 and 5.15 for [Ga-68]Ga-FAPI-46 PET/CT and [F-18]F-FDG PET/CT, respectively. Median TBRmax using blood pool was 18.45 versus 6.85 for [Ga-68]Ga-FAPI-46 PET/CT and [F-18]F-FDG PET/CT, respectively. Higher TBR also applies for nodal metastasis: TBRmax was 14.55 versus 1.39 (liver) and 7.97 versus 1.8 (blood pool) for [Ga-68]Ga-FAPI-46 PET/CT and [F-18]F-FDG PET/CT, respectively. Overall, [Ga-68]Ga-FAPI-46 PET/CT detected more lesions compared with [F-18]F-FDG PET/CT. Following surgical staging, a total of 5 metastatic LNs could be pathologically confirmed, of which 2 and 4 were positive by [F-18]F-FDG PET/CT and [Ga-68]Ga-FAPI-46 PET/CT, respectively.Conclusion[Ga-68]Ga-FAPI-46 PET/CT seems useful to improve detection of nodal metastasis in patients with CCs. Future studies should aim to compare [Ga-68]Ga-FAPI-46 PET/CT to surgical staging of pelvic and para-aortic LNs in patients with locally advanced CC.
引用
收藏
页码:150 / 155
页数:6
相关论文
共 50 条
  • [41] Comparison of 68Ga-FAPI PET CT/MRI and 18F-FDG PET/CT in metastatic lesions of gynecological cancers: a systematic review and head-to-head meta-analysis
    Sun, Lixin
    Hao, Pan
    Peng, Ruchen
    ACTA RADIOLOGICA, 2024,
  • [42] Clinical Usefulness of 18F-FDG PET/CT for Staging Cancer of the External Auditory Canal
    Toriihara, Akira
    Nakadate, Masashi
    Fujioka, Tomoyuki
    Oyama, Jun
    Tsutsumi, Takeshi
    Asakage, Takahiro
    Tsunoda, Atsunobu
    Tateishi, Ukihide
    OTOLOGY & NEUROTOLOGY, 2018, 39 (05) : E370 - E375
  • [43] 18F-FDG-PET/CT is of limited value in primary staging of early stage cervical cancer
    Dearbhail O. Driscoll
    Darragh Halpenny
    Ciaran Johnston
    Niall Sheehy
    Mary Keogan
    Abdominal Imaging, 2015, 40 : 127 - 133
  • [44] 18F-FDG-PET/CT is of limited value in primary staging of early stage cervical cancer
    Driscoll, Dearbhail O.
    Halpenny, Darragh
    Johnston, Ciaran
    Sheehy, Niall
    Keogan, Mary
    ABDOMINAL IMAGING, 2015, 40 (01): : 127 - 133
  • [45] Characteristics of thyroid incidentalomas detected by pre-treatment [18F]FDG PET or PET/CT in patients with cervical cancer
    Lee, Won-Moo
    Kim, Beob-Jong
    Kim, Moon-Hong
    Choi, Seok-Cheol
    Ryu, Sang-Young
    Lim, Ilhan
    Kim, Kidong
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2012, 23 (01) : 43 - 47
  • [46] Comparative Diagnostic Value of 18F-FDG-PET-CT and Intraoperative Examination in Cervical Cancer Staging
    Malenkovic, Goran
    Malenkovic, Jelena
    Tomic, Sanja
    Sljivo, Armin
    Gavrankapetanovic-Smailbegovic, Fatima
    Tomic, Slobodan
    MEDICINA-LITHUANIA, 2024, 60 (11):
  • [47] Preoperative [18F]FDG PET/CT predicts recurrence in patients with epithelial ovarian cancer
    Chung, Hyun Hoon
    Kwon, Hyun Woo
    Kang, Keon Wook
    Kim, Jae Weon
    Park, Noh-Hyun
    Song, Yong-Sang
    Kang, Soon-Beom
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2012, 23 (01) : 28 - 34
  • [48] The Role of [18F]FDG PET/CT in Monitoring of Therapy Response in Lung Cancer
    Ayeni, Akinwale
    Evbuomwan, Osayande
    Vangu, Mboyo-Di-Tamba Willy
    SEMINARS IN NUCLEAR MEDICINE, 2025, 55 (02) : 175 - 189
  • [49] Clinical value of [18F]FDG-PET/CT in the detection of metastatic medullary thyroid cancer
    Jiang, Jinjin
    Yang, Zhongyi
    Zhang, Yongping
    Xu, Xiaoping
    Wang, Mingwei
    Hu, Silong
    Yao, Zhifeng
    Pan, Herong
    Zhang, Yingjian
    Li, Duanshu
    CLINICAL IMAGING, 2014, 38 (06) : 797 - 801
  • [50] Influence of Biological Parameters Assessed in [18F]FDG PET/CT on Overall Survival in Cervical Cancer Patients
    Cegla, Paulina
    Burchardt, Ewa
    Roszak, Andrzej
    Czepczynski, Rafal
    Kubiak, Anna
    Cholewinski, Witold
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (11) : 860 - 863